	Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B41 Clinical Trial Validation. Clin Cancer Res Bharadwaj S, Corredor G, Al-Shakhshir H, Medina S, Almahfouz SN, Dhamdhere R, Pathak T, Fu P, Liu Y, Gandhi S, Badve S, Madabhushi A. PMID: 41915435 [PubMed - as supplied by publisher]
	Dance Interventions Improve Quality of Life and Related Psychological Factors Among Breast Cancer Survivors: A Systematic Review and Meta-Analysis. Psych J Chen T, Jiang L, Xu X, Jiang C. PMID: 41915303 [PubMed - indexed for MEDLINE]
	The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival. Breast Cancer Res Treat Decker KM, Feely A, Pitz M, Hebbard P, Kim JO, Czaykowski P, Singh H, Bucher O, Musto G, Lambert P. PMID: 41915268 [PubMed - indexed for MEDLINE]
	The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancer. Breast Cancer Res Treat Kupis W, K, Harhala M, Seku, Pogoda K, Borysowski J. PMID: 41915264 [PubMed - indexed for MEDLINE]
	Geographic Differences in Patient Experience After a Diagnosis of Lobular Breast Cancer. Ann Surg Oncol Graham-Stephenson A, Fanning CE, Geven EL, Migyanka F, Jeruss JS. PMID: 41915086 [PubMed - as supplied by publisher]
	Navigating chemoresistance in triple-negative breast cancer: interplay between molecular signalling pathways and immune microenvironment. Mol Biol Rep Mohamad Hanif EA, Azman AA, Md Zin RR. PMID: 41915084 [PubMed - in process]
	Psychosocial factors influencing opioid use and refusal among breast cancer survivors: A multi-methods study. J Health Psychol Chavez MN, Lubotsky Levin B, Beckstead J, Rigg KK, Marshall VK, Lubrano B, Martinez Tyson D. PMID: 41914761 [PubMed - as supplied by publisher]
	Prognostic Significance of Pretreatment Â¹â¸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine Therapy. Korean J Radiol Suh M, Ryu J, Song H, Jeong JH, Han S, Jeong H, Kim JE, Shin Y, Jeong BK, Lee HJ, Gong G, Ahn JH, Jung KH, Kim SB, Moon DH. PMID: 41914486 [PubMed - indexed for MEDLINE]
	Investigation female health workers' attitudes and awareness levels towards cancer screening. Afr J Reprod Health Akbulut , Gündo. PMID: 41914474 [PubMed - indexed for MEDLINE]
	Mitochondrial Metabolism in Breast Cancer. Front Biosci (Landmark Ed) Hu Q, Luo Z, Yuan W, Zou Q, Wang L, He Y, Shen Y, Wen X, Chen S, Liu Q, Luo D, Guo Z. PMID: 41914297 [PubMed - indexed for MEDLINE]
	Triple Assessment in the Clinical Evaluation of Ductal Breast Disease. Mymensingh Med J Sultana F, Aziz SR, Ara I, Farruk MM, Nusrat F. PMID: 41914117 [PubMed - indexed for MEDLINE]
	Pilot study: prognostic significance of semi-quantitative parameters in baseline fluorineâ€‘18 fluorodeoxyglucose PET/computed tomography in nonmetastatic breast cancer patients. Nucl Med Commun Elsayed ND, Mohamed MT, Abou Gabal MA, Azab RHI, Ahmed MS. PMID: 41913663 [PubMed - as supplied by publisher]
	A Five-Year Retrospective Analysis of Neoadjuvant Therapy in Early-Stage Breast Cancer: Subtype Outcomes and Imaging Concordance. Breast J Javed SR, DeSouza K, Tanzim U, Ottaviani D, Roylance R, Raja F, Walsh T, Koutoukoglou P, Creed C, McFarlane E, Mathur S, Mahapatra A, Papadimitraki E. PMID: 41913651 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer. Ann Surg Oncol Gallagher K, Feldman S, Barone J, Mammen J, Barone R, Ochoa D, McGinness M, Frazer T, Viscusi R, Lang JE, Lee J, Adkins LL, Johnson S, Henry-Tillman R, Korourian S, Suzanne Klimberg V. PMID: 41913021 [PubMed - as supplied by publisher]
	Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer. Ann Surg Oncol Shern TP, Holt LR, Lloyd K, Daly AE, Gadd MA, Verdial FC, Kwait RM, Specht MC, Smith BL, Ozmen T. PMID: 41913016 [PubMed - as supplied by publisher]
	A Hybrid Multi-CNN Feature Fusion and LASSO Optimization Approach for High-Performance Breast Cancer Classification. J Imaging Inform Med Beghriche T, Djerioui M, Brik Y, Attallah B, Shayea I. PMID: 41912956 [PubMed - as supplied by publisher]
	Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer-comparing real-world outcomes in England to the MONARCH-2 trial. Br J Cancer Anderson J, Lawton S, Thackray K, Kipps E. PMID: 41912678 [PubMed - as supplied by publisher]
	Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis. Br J Cancer Mavaddat N, Barnes DR, Michailidou K, Zhao E, Frost D, Leslie G, Dennis J, Wang Q, Bolla MK, EMBRACE, Evans DG, Tischkowitz M, Thompson DJ, Perry JRB, Antoniou AC, Easton DF. PMID: 41912676 [PubMed - as supplied by publisher]
	Novel targeted therapies and immunological strategies for breast cancer treatment. Biochem Pharmacol Mussa A, Hamid M, Talib M, Ehinnou I, Bragoli A, Hajisa K, Mokhtar NF, Mohamud R, Al-Hatamleh MAI, Hassan R. PMID: 41912055 [PubMed - as supplied by publisher]
	Profillin-1 and Transgelin-2: Actin Binding Proteins Expression in Early and Advanced Stages of Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancer Rep (Hoboken) Shahid MA, Mushtaq S, Khan A, Naseeb U, Haider G, Wasim B. PMID: 41911947 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 216170

Page 1 of 10809



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy